Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function

Scott E. Collibee, Gustave Bergnes, Chih-Yuan Chuang, Luke Ashcraft, Jeffrey Gardina, Marc Garard, Chris R. Jamison, Kevin Lu, Pu‐Ping Lu, Alexander R. Muci,

Journal of Medicinal Chemistry · 2021 · 25 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

muscle activation potency compared to the first-generation FSTA, tirasemtiv. Reldesemtiv demonstrated increased muscle force generation in a phase 1 clinical trial and is currently being evaluated in clinical trials for the treatment of amyotrophic lateral sclerosis.

References

18